Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
Interstitial lung diseases (ILD) are a heterogeneous group of chronic disorders leading to progressive lung damage and ...
For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown. Stereotactic ablative radiotherapy (SABR) has ...
The study also presented the first external validation and use in patients with early RA of six proposed screening strategies for RA-associated ILD.
Credit: Shutterstock. The application is supported by data from the phase 3 InPedILD trial. The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for ...
Fibrotic interstitial lung disease (fibrotic ILD) entails a spectrum of different clinical entities characterised by an ...
Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases. Janet ...
Researchers at the University of Exeter and clinical radiopharmaceutical company Serac Healthcare Ltd are researching a new molecular imaging marker which could help to detect disease progression ...
Patients with inflammatory bowel disease (IBD) had a significantly higher risk for developing interstitial lung disease (ILD) compared with the general population and siblings who do not have the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback